National Academies Press: OpenBook
« Previous: Appendix B Workshop Agenda
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

C

Registered Attendees

Jane Acri

National Institute on Drug Abuse

Andrew Ahn

Eli Lilly and Company

Seun Ajiboye

American Association for Dental Research

Seena Ajit

Drexel University College of Medicine

Mohammed Akbar

National Institute on Alcohol Abuse and Alcoholism

Susan Amara

National Institute of Mental Health

Rachel Anderson

American Association for the Advancement of Science

Angela Arensdorf

National Center for Complementary and Integrative Care

Shilli Avenevoli

National Institute of Mental Health

Susan Awad

American Society of Addiction Medicine

Lisa Bain

Lisa Bain, LLC

Rita Balice-Gordon

Sanofi, Inc.

Inna Belfer

National Institutes of Health

Christina Berry

ADVI Health, LLC

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Ellen Blackwell

Centers for Medicare & Medicaid Services

Lizbet Boroughs

Association of American Universities

Richard Boyce

Veterans Affairs Medical Center

Maureen Boyle

National Institute on Drug Abuse

Josephine Briggs

National Center for Complementary and Integrative Health

Katja Brose

Chan Zuckerberg Initiative

Emery Brown

Massachusetts Institute of Technology

Dorothy Brown

Eli Lilly and Company – Elanco

Michael Brown

GE Global Research

Sarah Caddick

Gatsby Charitable Foundation

Erin Cadwalader

Lewis-Burke Associates

Brian Campbell

MindImmune Therapeutics

Rosa Canet-Aviles

Foundation for the National Institutes of Health

Jooyoung Cha

Department of Health and Human Services

Timothy Coetzee

National Multiple Sclerosis Society

Jonathan Cohen

Princeton University

Wilson Compton

National Institute on Drug Abuse

Roger Crystal

Opiant Pharmaceuticals

Marc Cuesta

Brain Canada

Katherine Dawson

Biogen

Joan Demetriades

One Mind

Luda Diatchenko

McGill University

E. Ray Dorsey

University of Rochester

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Martin Duenas

Leidos

John Dunlop

Amgen

Robert Dworkin

University of Rochester School of Medicine

Emmeline Edwards

National Center for Complementary and Integrative Health

Mark Egli

National Institute on Alcohol Abuse and Alcoholism

Anne Esposito

Indivior, Inc.

Dorothy Farrell

American Association of Colleges of Pharmacy

Christopher Flores

Johnson & Johnson Consumer, Inc.

Danielle Friend

BIO

Crina Frincu

National Institute of Dental and Craniofacial Research

Gary Fujii

Molecular Express, Inc.

Brendon Gehrke

Department of Veterans Affairs

Robert Gereau

Washington University School of Medicine

Joshua Gordon

National Institute of Mental Health

Christopher Gorini

Food and Drug Administration

Magali Haas

Cohen Veterans Bioscience

Tariq Habib

Alkarim Traders International

Mohamed Hachicha

National Institute of Neurological Disorders and Stroke

Bruce Hammock

EicOsis Human Health

Dean Hartley

Alzheimer’s Association

Christian Heidbreder

Indivior, Inc.

Laura Helbling

The RPM Report

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Sharon Hertz

Food and Drug Administration

Tom Hill

National Council for Behavioral Health

Carrie Hill

National Sheriffs Association

Sam On Ho

Molecular Express, Inc.

Richard Hodes

National Institute on Aging

Stuart Hoffman

Department of Veterans Affairs

Steven Hyman

Broad Institute of Massachusetts Institute of Technology and Harvard University

Michael Irizarry

Eli Lilly and Company

Inez Jabalpurwala

Brain Canada

Abdulmajeed Jali

Virginia Commonwealth University

Jori Kandra

University of Texas System

Petra Kaufmann

National Center for Advancing Translational Sciences

John Kehne

National Institute of Neurological Disorders and Stroke

Andrew Kessler

Slingshot Solutions

Mary Beth Kester

National Center for Complementary and Integrative Health

Partap Khalsa

National Center for Complementary and Integrative Health

Shannon Kirkland

National Education Association

Brian Klein

National Institute of Neurological Disorders and Stroke

Walter Koroshetz

National Institute of Neurological Disorders and Stroke

Elena Koustova

National Institute on Drug Abuse

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Alexander Kraus

Self-Employed

Audrey Kusiak

Department of Veterans Affairs

Deep Kwatra

Food and Drug Administration

Pascal Laeng

National Institute of Neurological Disorders and Stroke

Vanessa Lamers

Public Health Foundation

Story Landis

National Institute of Neurological Disorders and Stroke (emeritus)

Deborah Leiderman

CNS Drug Consulting, LLC

Shari Ling

Centers for Medicare & Medicaid Services

Sean Mackey

Stanford School of Medicine

William Maixner

Duke University

Ronald Marcus

Cerecor

Sopio Mataradze

DAC

David McCann

National Institute on Drug Abuse

Owen McManus

Q-State Biosciences

Abdeljalil Mekkaoui

Self-Employed

David Michelson

Merck

Ivan Montoya

National Institute on Drug Abuse

Grace Moser

Prevision Policy, LLC

Chris Naso

Community Anti-Drug Coalition of America

Mei-Hing Ng

Tsaotun Psychiatric Center, Taiwan

Jessica Hulsey Nickel

Addiction Policy Forum

Kathy Orellana

American Psychiatric Association

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Andrey Ostrovsky

Center for Medicaid and CHIP Services

Bryan Parker

International Healthcare

Julia Pinto

Food and Drug Administration

Leah Pog

National Institute of Neurological Disorders and Stroke

Linda Porter

National Institute of Neurological Disorders and Stroke

Scott Powers

Cincinnati Children’s Hospital Medical Center; University of Cincinnati College of Medicine

Theodore Price

The University of Texas at Dallas

Khara Ramos

National Institute of Neurological Disorders and Stroke

Beeta Rasouli

Lewis-Burke Associates

Soundar Regunathan

National Institute on Alcohol Abuse and Alcoholism

Alicia Richmond Scott

Department of Health and Human Services

Carol Robertson-Plouch

Biopharmaceutical Advisors and Consultants

Becky Roof

National Institute of Nursing Research

Tarek Samad

Pfizer Inc.

Friedhelm Sandbrink

Veterans Health Administration

Cheryse Sankar

National Institute of Neurological Disorders and Stroke

Eugenia Schenecker

The George Washington University

Richard Schottenfeld

Howard University College of Medicine

Nikki Semenza

Community Anti-Drug Coalition

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Marilyn Serafini

Health Policy Translation

Danielle Shapiro

National Center for Health Research

Robert Shibuya

Food and Drug Administration

David Shurtleff

National Center for Complementary and Integrative Medicine

Lily Silayeva

The Tauri Group

Christopher Spevak

Walter Reed National Military Medical Center

Jack Stein

National Institute on Drug Abuse

Jim Sullivan

AbbVie, Inc.

Margaret Sutherland

National Institute of Neurological Disorders and Stroke

Edmund Talley

National Institute of Neurological Disorders and Stroke

Amir Tamiz

National Institute of Neurological Disorders and Stroke

Wendy Toler

Consultant

Drew Townsend

Virginia Commonwealth University

Yoland Vallejo

National Institute of Dental and Craniofacial Research

Christin Veasley

Chronic Pain Research Alliance

Kenneth Verburg

Pfizer Inc.

Nora Volkow

National Institute on Drug Abuse

Tor Wager

University of Colorado Boulder

Sharon Walsh

University of Kentucky

Ashley Walton

American Society of Anesthesiologists

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×

Jacqueline Ward

National Institute of Neurological Disorders and Stroke

Lynn Webster

PRA Health Sciences

Andrew Welchman

Wellcome Trust

Cole Werble

Prevision Policy, LLC

David White

National Institute on Drug Abuse

Clifford Woolf

Boston Children’s Hospital; Harvard Medical School

Nicole Wrigley

SeekHealing

Tony Yaksh

University of California, San Diego

Stevin Zorn

The University of Rhode Island; MindImmune Therapeutics, Inc.

Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 87
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 88
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 89
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 90
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 91
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 92
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 93
Suggested Citation:"Appendix C Registered Attendees." National Academies of Sciences, Engineering, and Medicine. 2018. Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25060.
×
Page 94
Advancing Therapeutic Development for Pain and Opioid Use Disorders Through Public-Private Partnerships: Proceedings of a Workshop Get This Book
×
Buy Paperback | $45.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Chronic pain is one of the most prevalent, costly, and disabling health conditions in the United States. Estimates show that more than 11 percent of the American population suffer from chronic pain, yet the federal pain research investment has been minimal. In parallel with a gradual increased recognition of the problems of treating chronic pain, the opioid epidemic has emerged as a growing public health emergency. The intersection of these two crises lies in the fact that an unintended consequence of treating pain has been an increasing number of opioid prescriptions and diversion of drugs for illicit purposes.

In May 2017, the National Institutes of Health (NIH), and the National Institute on Drug Abuse announced a public–private partnership to develop solutions to the opioid crisis and cut in half the time it takes to develop non-addictive analgesics. To advance the planning of NIH’s anticipated public–private partnerships, the National Academies’ Forum on Neuroscience and Nervous Systems Disorders hosted a public workshop that brought together a diverse group of stakeholders from academia, federal agencies, advocacy organizations and companies developing therapeutics for pain and opioid use disorders. Participants discussed potential strategies to accelerate development of non-addictive pain medications and treatments for opioid use disorders. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!